This report contains market size and forecasts of Capecitabine Fumarate in global, including the following market information:
Global Capecitabine Fumarate Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Capecitabine Fumarate Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Capecitabine Fumarate companies in 2020 (%)
The global Capecitabine Fumarate market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Capecitabine Fumarate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Capecitabine Fumarate Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Capecitabine Fumarate Market Segment Percentages, By Type, 2020 (%)
Capecitabine Fumarate Oral
Capecitabine Fumarate Infusion
Global Capecitabine Fumarate Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Capecitabine Fumarate Market Segment Percentages, By Application, 2020 (%)
Breast Cancer
Rectal Cancer
Colon Cancer
Gastric Cancer
Other Malignancies
Global Capecitabine Fumarate Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Capecitabine Fumarate Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Capecitabine Fumarate revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Capecitabine Fumarate revenues share in global market, 2020 (%)
Key companies Capecitabine Fumarate sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Capecitabine Fumarate sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Sun Pharma Global
Pfizer
Dr Reddys
Mylan
Sagent Pharms
Akorn
Emcure Pharms
Hikma Farmaceutica
Gland Pharma
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Capecitabine Fumarate Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Capecitabine Fumarate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Capecitabine Fumarate Overall Market Size
2.1 Global Capecitabine Fumarate Market Size: 2021 VS 2027
2.2 Global Capecitabine Fumarate Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Capecitabine Fumarate Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Capecitabine Fumarate Players in Global Market
3.2 Top Global Capecitabine Fumarate Companies Ranked by Revenue
3.3 Global Capecitabine Fumarate Revenue by Companies
3.4 Global Capecitabine Fumarate Sales by Companies
3.5 Global Capecitabine Fumarate Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Capecitabine Fumarate Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Capecitabine Fumarate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Capecitabine Fumarate Players in Global Market
3.8.1 List of Global Tier 1 Capecitabine Fumarate Companies
3.8.2 List of Global Tier 2 and Tier 3 Capecitabine Fumarate Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Capecitabine Fumarate Market Size Markets, 2021 & 2027
4.1.2 Capecitabine Fumarate Oral
4.1.3 Capecitabine Fumarate Infusion
4.2 By Type - Global Capecitabine Fumarate Revenue & Forecasts
4.2.1 By Type - Global Capecitabine Fumarate Revenue, 2016-2021
4.2.2 By Type - Global Capecitabine Fumarate Revenue, 2022-2027
4.2.3 By Type - Global Capecitabine Fumarate Revenue Market Share, 2016-2027
4.3 By Type - Global Capecitabine Fumarate Sales & Forecasts
4.3.1 By Type - Global Capecitabine Fumarate Sales, 2016-2021
4.3.2 By Type - Global Capecitabine Fumarate Sales, 2022-2027
4.3.3 By Type - Global Capecitabine Fumarate Sales Market Share, 2016-2027
4.4 By Type - Global Capecitabine Fumarate Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Capecitabine Fumarate Market Size, 2021 & 2027
5.1.2 Breast Cancer
5.1.3 Rectal Cancer
5.1.4 Colon Cancer
5.1.5 Gastric Cancer
5.1.6 Other Malignancies
5.2 By Application - Global Capecitabine Fumarate Revenue & Forecasts
5.2.1 By Application - Global Capecitabine Fumarate Revenue, 2016-2021
5.2.2 By Application - Global Capecitabine Fumarate Revenue, 2022-2027
5.2.3 By Application - Global Capecitabine Fumarate Revenue Market Share, 2016-2027
5.3 By Application - Global Capecitabine Fumarate Sales & Forecasts
5.3.1 By Application - Global Capecitabine Fumarate Sales, 2016-2021
5.3.2 By Application - Global Capecitabine Fumarate Sales, 2022-2027
5.3.3 By Application - Global Capecitabine Fumarate Sales Market Share, 2016-2027
5.4 By Application - Global Capecitabine Fumarate Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Capecitabine Fumarate Market Size, 2021 & 2027
6.2 By Region - Global Capecitabine Fumarate Revenue & Forecasts
6.2.1 By Region - Global Capecitabine Fumarate Revenue, 2016-2021
6.2.2 By Region - Global Capecitabine Fumarate Revenue, 2022-2027
6.2.3 By Region - Global Capecitabine Fumarate Revenue Market Share, 2016-2027
6.3 By Region - Global Capecitabine Fumarate Sales & Forecasts
6.3.1 By Region - Global Capecitabine Fumarate Sales, 2016-2021
6.3.2 By Region - Global Capecitabine Fumarate Sales, 2022-2027
6.3.3 By Region - Global Capecitabine Fumarate Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Capecitabine Fumarate Revenue, 2016-2027
6.4.2 By Country - North America Capecitabine Fumarate Sales, 2016-2027
6.4.3 US Capecitabine Fumarate Market Size, 2016-2027
6.4.4 Canada Capecitabine Fumarate Market Size, 2016-2027
6.4.5 Mexico Capecitabine Fumarate Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Capecitabine Fumarate Revenue, 2016-2027
6.5.2 By Country - Europe Capecitabine Fumarate Sales, 2016-2027
6.5.3 Germany Capecitabine Fumarate Market Size, 2016-2027
6.5.4 France Capecitabine Fumarate Market Size, 2016-2027
6.5.5 U.K. Capecitabine Fumarate Market Size, 2016-2027
6.5.6 Italy Capecitabine Fumarate Market Size, 2016-2027
6.5.7 Russia Capecitabine Fumarate Market Size, 2016-2027
6.5.8 Nordic Countries Capecitabine Fumarate Market Size, 2016-2027
6.5.9 Benelux Capecitabine Fumarate Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Capecitabine Fumarate Revenue, 2016-2027
6.6.2 By Region - Asia Capecitabine Fumarate Sales, 2016-2027
6.6.3 China Capecitabine Fumarate Market Size, 2016-2027
6.6.4 Japan Capecitabine Fumarate Market Size, 2016-2027
6.6.5 South Korea Capecitabine Fumarate Market Size, 2016-2027
6.6.6 Southeast Asia Capecitabine Fumarate Market Size, 2016-2027
6.6.7 India Capecitabine Fumarate Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Capecitabine Fumarate Revenue, 2016-2027
6.7.2 By Country - South America Capecitabine Fumarate Sales, 2016-2027
6.7.3 Brazil Capecitabine Fumarate Market Size, 2016-2027
6.7.4 Argentina Capecitabine Fumarate Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Capecitabine Fumarate Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Capecitabine Fumarate Sales, 2016-2027
6.8.3 Turkey Capecitabine Fumarate Market Size, 2016-2027
6.8.4 Israel Capecitabine Fumarate Market Size, 2016-2027
6.8.5 Saudi Arabia Capecitabine Fumarate Market Size, 2016-2027
6.8.6 UAE Capecitabine Fumarate Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Capecitabine Fumarate Major Product Offerings
7.1.4 Novartis Capecitabine Fumarate Sales and Revenue in Global (2016-2021)
7.1.5 Novartis Key News
7.2 Sun Pharma Global
7.2.1 Sun Pharma Global Corporate Summary
7.2.2 Sun Pharma Global Business Overview
7.2.3 Sun Pharma Global Capecitabine Fumarate Major Product Offerings
7.2.4 Sun Pharma Global Capecitabine Fumarate Sales and Revenue in Global (2016-2021)
7.2.5 Sun Pharma Global Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Capecitabine Fumarate Major Product Offerings
7.3.4 Pfizer Capecitabine Fumarate Sales and Revenue in Global (2016-2021)
7.3.5 Pfizer Key News
7.4 Dr Reddys
7.4.1 Dr Reddys Corporate Summary
7.4.2 Dr Reddys Business Overview
7.4.3 Dr Reddys Capecitabine Fumarate Major Product Offerings
7.4.4 Dr Reddys Capecitabine Fumarate Sales and Revenue in Global (2016-2021)
7.4.5 Dr Reddys Key News
7.5 Mylan
7.5.1 Mylan Corporate Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Capecitabine Fumarate Major Product Offerings
7.5.4 Mylan Capecitabine Fumarate Sales and Revenue in Global (2016-2021)
7.5.5 Mylan Key News
7.6 Sagent Pharms
7.6.1 Sagent Pharms Corporate Summary
7.6.2 Sagent Pharms Business Overview
7.6.3 Sagent Pharms Capecitabine Fumarate Major Product Offerings
7.6.4 Sagent Pharms Capecitabine Fumarate Sales and Revenue in Global (2016-2021)
7.6.5 Sagent Pharms Key News
7.7 Akorn
7.7.1 Akorn Corporate Summary
7.7.2 Akorn Business Overview
7.7.3 Akorn Capecitabine Fumarate Major Product Offerings
7.4.4 Akorn Capecitabine Fumarate Sales and Revenue in Global (2016-2021)
7.7.5 Akorn Key News
7.8 Emcure Pharms
7.8.1 Emcure Pharms Corporate Summary
7.8.2 Emcure Pharms Business Overview
7.8.3 Emcure Pharms Capecitabine Fumarate Major Product Offerings
7.8.4 Emcure Pharms Capecitabine Fumarate Sales and Revenue in Global (2016-2021)
7.8.5 Emcure Pharms Key News
7.9 Hikma Farmaceutica
7.9.1 Hikma Farmaceutica Corporate Summary
7.9.2 Hikma Farmaceutica Business Overview
7.9.3 Hikma Farmaceutica Capecitabine Fumarate Major Product Offerings
7.9.4 Hikma Farmaceutica Capecitabine Fumarate Sales and Revenue in Global (2016-2021)
7.9.5 Hikma Farmaceutica Key News
7.10 Gland Pharma
7.10.1 Gland Pharma Corporate Summary
7.10.2 Gland Pharma Business Overview
7.10.3 Gland Pharma Capecitabine Fumarate Major Product Offerings
7.10.4 Gland Pharma Capecitabine Fumarate Sales and Revenue in Global (2016-2021)
7.10.5 Gland Pharma Key News
8 Global Capecitabine Fumarate Production Capacity, Analysis
8.1 Global Capecitabine Fumarate Production Capacity, 2016-2027
8.2 Capecitabine Fumarate Production Capacity of Key Manufacturers in Global Market
8.3 Global Capecitabine Fumarate Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Capecitabine Fumarate Supply Chain Analysis
10.1 Capecitabine Fumarate Industry Value Chain
10.2 Capecitabine Fumarate Upstream Market
10.3 Capecitabine Fumarate Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Capecitabine Fumarate Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Capecitabine Fumarate in Global Market
Table 2. Top Capecitabine Fumarate Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Capecitabine Fumarate Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Capecitabine Fumarate Revenue Share by Companies, 2016-2021
Table 5. Global Capecitabine Fumarate Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Capecitabine Fumarate Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Capecitabine Fumarate Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Capecitabine Fumarate Product Type
Table 9. List of Global Tier 1 Capecitabine Fumarate Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Capecitabine Fumarate Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Novartis
Sun Pharma Global
Pfizer
Dr Reddys
Mylan
Sagent Pharms
Akorn
Emcure Pharms
Hikma Farmaceutica
Gland Pharma